Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Poster Presentations: Acute and Chronic Complications

587-P: The Relationship between Metabolic Index, Liver Enzyme Index, and the Incidence of Diabetes: The Jinchang Cohort Study

  1. PEIYAO HUANG,
  2. JINGLI YANG,
  3. WENYA HUANG,
  4. NIAN LIU,
  5. RUONAN WANG,
  6. RUI ZHANG,
  7. ZHAO BAI,
  8. YANA BAI,
  9. NING CHENG,
  10. MINZHEN WANG and
  11. SHAN ZHENG
  1. Gansu, China, Lanzhou, China
Diabetes 2020 Jun; 69(Supplement 1): -. https://doi.org/10.2337/db20-587-P
Previous
  • Article
  • Info & Metrics
Loading

Abstract

Objectives: To explore the incidence of diabetes under different indicator and interaction between metabolic index and liver enzyme index for diabetes mellitus.

Methods: This study based on the Jinchang cohort, which is a prospective cohort included 48,001 subjects at baseline. To compare the incidence of diabetes under different metabolic indexes and liver enzyme indexes; Cox proportional hazard model was used to analysis the risk of diabetes with different metabolic indexes and liver enzymes indexes; The multiplicative model was used to analyze the interaction between different metabolic indexes and liver enzymes indexes for diabetes.

Results: With the increase of TC, TG, ALT and AST, the incidence of diabetes gradually increased(p<0.05), with the increase of HDL-C level, the incidence of diabetes gradually decreased(p<0.05).With the increase of TC, TG, LDL-C, ALT, AST and GGT, the risk of diabetes were rising(p<0.05), and the increase of HDL-C reduced the risk of diabetes. In men, the interaction between TC and TG, TC and ALT, TG and ALT, ALT and GGT are positively and multiply; which HR(95%CI) was 6.71 (1.66∼27.04),20.62(9.50∼44.76),10.23(6.42∼16.29) and 6.63(4.38∼10.04), respectively. In women, TC and TG, ALT and GGT are positively and multiply, they also play a synergistic role in the risk of diabetes, and the HR(95%CI) was 6.75(2.12∼21.50) and 15.93(4.95∼51.25), respectively.

Conclusion: TC, TG, LDL-C,ALT, AST and GGT were risk factors for the incidence of diabetes, and HDL-C was a protective factor for the incidence of diabetes. In the male population, the interaction of TC and TG, TC and ALT, TG and ALT, ALT and GGT were all positively multiplied. In the female population, TC and TG, ALT and GGT were positively multiplied by the interaction.

Disclosure P. Huang: None. J. Yang: None. W. Huang: None. N. Liu: None. R. Wang: None. R. Zhang: None. Z. Bai: None. Y. Bai: None. N. Cheng: None. M. Wang: None. S. Zheng: None.

Funding National Institutes of Health (1R01ES02908201A1); Lanzhou University (2018LDBRZD008)

  • © 2020 by the American Diabetes Association
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

Previous
Back to top
Diabetes: 69 (Supplement 1)

In this Issue

June 2020, 69(Supplement 1)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
587-P: The Relationship between Metabolic Index, Liver Enzyme Index, and the Incidence of Diabetes: The Jinchang Cohort Study
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
587-P: The Relationship between Metabolic Index, Liver Enzyme Index, and the Incidence of Diabetes: The Jinchang Cohort Study
PEIYAO HUANG, JINGLI YANG, WENYA HUANG, NIAN LIU, RUONAN WANG, RUI ZHANG, ZHAO BAI, YANA BAI, NING CHENG, MINZHEN WANG, SHAN ZHENG
Diabetes Jun 2020, 69 (Supplement 1) 587-P; DOI: 10.2337/db20-587-P

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

587-P: The Relationship between Metabolic Index, Liver Enzyme Index, and the Incidence of Diabetes: The Jinchang Cohort Study
PEIYAO HUANG, JINGLI YANG, WENYA HUANG, NIAN LIU, RUONAN WANG, RUI ZHANG, ZHAO BAI, YANA BAI, NING CHENG, MINZHEN WANG, SHAN ZHENG
Diabetes Jun 2020, 69 (Supplement 1) 587-P; DOI: 10.2337/db20-587-P
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics

Related Articles

Cited By...

More in this TOC Section

Poster Presentations: Acute and Chronic Complications

  • 494-P: Effects of a Novel Xanthine Oxidase Inhibitor, TMX-049, on Urinary Albumin Excretion in Patients with Type 2 Diabetes and Albuminuria
  • 489-P: Energy Status Could Modulate Autophagy through Colocalizations of Fyn, P53, and Tgm2 in the Renal Tubules In Vivo
  • 531-P: Metabolomics Identifies Novel Plasma Metabolomic Signatures Associated with Diabetic Neuropathy in a Cohort with Screen-Tested Type 2 Diabetes: ADDITION-Denmark
Show more Poster Presentations: Acute and Chronic Complications

P: Diabetic Dyslipidemia

  • 580-P: Role of Bile Acids in Hepatic Lipid Metabolism: Characterization of the Fasting Lipid and Lipoprotein Profile of Tgr5-/- Hamsters
  • 579-P: Dyslipidemia in Type 2 Diabetic Mice Is Improved by Targeting Smad3 with a Smad3 Inhibitor SIS3
Show more P: Diabetic Dyslipidemia

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.